The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey-Reference-Cited by-同舟云学术

The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey

Published:2019-05-07 Issue:7 Volume:3 Page:1321-1334
ISSN:2472-1972
Container-title:Journal of the Endocrine Society
language:en
Short-container-title:

Author:

Skrinar Alison¹^ORCID,Dvorak-Ewell Melita¹,Evins Ayla¹,Macica Carolyn²,Linglart Agnès³,Imel Erik A⁴^ORCID,Theodore-Oklota Christina¹,San Martin Javier¹

Affiliation:

1. Ultragenyx Pharmaceutical Inc., Novato, California

2. Frank H. Netter School of Medicine, Quinnipiac University, North Haven, Connecticut

3. Hôpital Bicêtre, Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France

4. Indiana University School of Medicine, Indianapolis, Indiana

Funder

Ultragenyx Pharmaceutical

Publisher

The Endocrine Society

Subject

Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jes/advance-article-pdf/doi/10.1210/js.2018-00365/28559596/js.2018-00365.pdf

Reference49 articles.

1. A clinician’s guide to X-linked hypophosphatemia;Carpenter;J Bone Miner Res,2011

2. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark;Beck-Nielsen;Eur J Endocrinol,2009

3. Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment;Endo;Endocr J,2015

4. Hereditary hypophosphatemia in Norway; a retrospective population-based study of genotypes, phenotypes and treatment complications;Rafaelsen;Eur J Endocrinol,2016

5. Rickets;Carpenter;Nat Rev Dis Primers,2017

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of burosumab in improving phosphate metabolism, bone health, and quality of life in adolescents with X-linked hypophosphatemic rickets;European Journal of Medical Genetics;2024-08

2. X-linked hypophosphataemia;The Lancet;2024-08

3. Inherited phosphate and pyrophosphate disorders;The Journal of the American Dental Association;2024-08

4. Improved Oral Health in Adults With X-Linked Hypophosphatemia Treated With Burosumab;The Journal of Clinical Endocrinology & Metabolism;2024-06-12

5. Burosumab treatment of X-linked hypophosphatemia patients: interim analysis of the SUNFLOWER longitudinal, observational cohort study;JBMR Plus;2024-06-10